Science & Technology EMBL Heidelberg researchers compared the effect of drugs on isolated bacteria versus those growing in communities. This is the first study showing that bacteria are more resilient when in community due to cross-protection strategies. This could help researchers design more efficient therapies.
2024
science-technology
Science & Technology Sponges lack muscles and neurons. Yet, they make coordinated movements. Scientists at EMBL Heidelberg have discovered that sponge movement is controlled by an ancient ‘relaxant-inflammatory’ response that is also present in vertebrate blood vessels. The findings shed light on sponge physiology…
2024
sciencescience-technology
Science & Technology A new collaborative study led by EMBL group leaders Kiran Patil, Nassos Typas, and Peer Bork has found that common medications accumulate in human gut bacteria. This process reduces drug effectiveness and affects the metabolism of common gut microbes, thereby altering the gut microbiome.
2021
sciencescience-technology
Science & Technology A team of EMBL scientists and colleagues have analysed how the novel coronavirus affects proteins in human cells. They identified several human proteins as potential drug targets to prevent viral replication.
2021
sciencescience-technology
Science & Technology A new paper from EMBL’s Savitski team and Typas group describes their work on E. coli and how it brings a greater understanding of the way genes function and interact.
2020
sciencescience-technology
Science & Technology EMBL researchers are studying how drugs that have shown good results against COVID-19 work in living cells
2020
sciencescience-technology
Science & Technology EMBL scientists identify drug targets in blood and organs
2020
sciencescience-technology
Science & Technology Scientists develop technology to measure how ATP concentration affects protein solubility in cells
2019
sciencescience-technology
Science & Technology EMBL scientists uncover large solubility and thermal stability changes of proteins during the cell cycle
2018
sciencescience-technology
Science & Technology Scientists at EMBL and Cellzome develop technology to monitor the effects of drug treatments on protein degradation and synthesis
2018
sciencescience-technology
Science & Technology EMBL scientists create a turnover catalogue of almost 10.000 proteins from primary cells
2018
sciencescience-technology
Science & Technology Side-effects of leukaemia drug explained, reveal possibility of repurposing to treat other diseases
2016
sciencescience-technology
People & Perspectives New head of Proteomics Core Facility also runs stability proteomics lab
2016
people-perspectivesscience
No matching posts found
Looking for past print editions of EMBLetc.? Browse our archive, going back 20 years.
EMBLetc. archive
